FDA Issues Advice on Replacement or Corrective Therapies for Certain Rare Diseases

The FDA released a draft guidance Thursday recommending ways to demonstrate if new drugs or drug uses are effective for certain low-prevalence rare diseases caused by single enzyme defects.
Source: Drug Industry Daily